Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
Petra Langerbeins, Barbara Eichhorst
Acta Haematologica (2021) Vol. 144, Iss. 5, pp. 508-518
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity
Yandong Shen, Jane A. Freeman, Juliette Holland, et al.
British Journal of Haematology (2021) Vol. 197, Iss. 1, pp. 41-51
Open Access | Times Cited: 41
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
Lisa Blixt, Gordana Bogdanović, Marcus Buggert, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 476-481
Open Access | Times Cited: 40
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Barbora Bacova, Zuzana Kohutová, Ivana Zubata, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 371-379
Open Access | Times Cited: 22
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
Roberta Murru, Andrea Galitzia, Luca Barabino, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1655-1664
Open Access | Times Cited: 5
Case Report: Detection of invasive mcr-10 harbouring Klebsiella quasipneumoniae subsp. similipneumoniae in a patient with chronic myeloid leukaemia.
Odion O. Ikhimiukor, Aaron O. Aboderin, Anderson O. Oaikhena, et al.
(2025)
Closed Access
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Ilana Levy, Avital Lavi, Eran Zimran, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 14, pp. 3384-3393
Closed Access | Times Cited: 30
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
Lisa Blixt, David Wullimann, Soo Aleman, et al.
Haematologica (2022) Vol. 107, Iss. 4, pp. 1000-1003
Open Access | Times Cited: 17
Vaccinations in patients with chronic lymphocytic leukemia
Elizabeth R. Francis, Jennifer Vu, Catherine ostos Perez, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 2, pp. 131-138
Closed Access | Times Cited: 3
Epidemiological and etiological characteristics of 1266 patients with severe acute respiratory infection in central China, 2018–2020: a retrospective survey
Jinzhu Wang, Ding Yuan, Xianghong Yang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
María Stefania Infante, Jon Salmanton‐García, Ana Fernández‐Cruz, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 558-558
Open Access | Times Cited: 13
Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis
Constantin A Dasanu, S.K. Mann, Melvin Baidya, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1525-1540
Closed Access | Times Cited: 2
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
Candida Vitale, Elia Boccellato, Lorenzo Comba, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3856-3856
Open Access | Times Cited: 16
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, Catherine Liu, Katherine Eakle, et al.
HemaSphere (2022) Vol. 7, Iss. 1, pp. e811-e811
Open Access | Times Cited: 12
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study
Paolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 5
B-cell malignancies and COVID-19: a narrative review
David Luque-Paz, Pierre Sesques, Florent Wallet, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 3, pp. 332-337
Open Access | Times Cited: 8
SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
Jakob J Malin, Veronica Di Cristanziano, Carola Horn, et al.
Blood Advances (2021) Vol. 6, Iss. 5, pp. 1580-1584
Open Access | Times Cited: 11
Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, et al.
Hematological Oncology (2023) Vol. 41, Iss. 4, pp. 621-630
Open Access | Times Cited: 4
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
Martin Šimkovič, Peter Turcsányi, Martin Špaček, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 811-817
Open Access | Times Cited: 4
Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Increased Frequency of Circulating Activated FOXP3+ Regulatory T-cell Subset in Patients with Chronic Lymphocytic Leukemia Is Associated with the Estimate of the Size of the Tumor Mass, STAT5 Signaling and Disease Course during Follow-Up of Patients
Zlatko Roškar, Mojca Dreisinger, Evgenija Homšak, et al.
(2024)
Open Access | Times Cited: 1
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid‐19 pandemics
Idanna Innocenti, Annamaria Tomasso, Giulia Benintende, et al.
Hematological Oncology (2022) Vol. 40, Iss. 3, pp. 469-474
Open Access | Times Cited: 6
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor
Amit Bar‐Or, Anne H. Cross, Anthony L. Cunningham, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 11-12, pp. 1471-1481
Open Access | Times Cited: 2
Chronic lymphocytic leukaemia Australasian consensus practice statement
Mary Ann Anderson, Rory Bennett, Xavier C. Badoux, et al.
Internal Medicine Journal (2023) Vol. 53, Iss. 9, pp. 1678-1691
Open Access | Times Cited: 2
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
Andrea Galitzia, Luca Barabino, Roberta Murru, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1162-1162
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top